Search hospitals
>
Illinois
>
Effingham
Crossroads Cancer Center
Claim this profile
Effingham, Illinois 62401
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast cancer
357 reported clinical trials
3 medical researchers
Summary
Crossroads Cancer Center is a medical facility located in Effingham, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Crossroads Cancer Center is involved with conducting 357 clinical trials across 447 conditions. There are 3 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, and Harold Yoon, MD.
Area of expertise
Lung Cancer
Crossroads Cancer Center has run 68 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Crossroads Cancer Center has run 61 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Bryan A. Faller
Crossroads Cancer Center
7 years of reported clinical research
James L. Wade
Decatur Memorial Hospital
4 years of reported clinical research
Harold Yoon, MD
Decatur Memorial Hospital
6 years of reported clinical research
Clinical Trials running at Crossroads Cancer Center
Lung Cancer
Prostate Cancer
Breast Cancer
Breast cancer
Cancer
Kidney Cancer
Pancreatic Cancer
Ovarian Cancer
Multiple Myeloma
Esophageal cancer
Radiotherapy
for Lung Cancer
This study is being done to answer the following question: Can the chance of lung cancer growing or spreading be lowered by adding targeted radiotherapy to the usual combination of drugs? This study is being done to find out if this approach is better or worse than the usual approach for lung cancer. The usual approach is defined as the care most people get for non-small cell lung cancer.
Recruiting
2 awards
Phase 3
4 criteria
Ceralasertib + Durvalumab
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of adding AZD6738 to durvalumab versus durvalumab alone to increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery. AZD6738 may stop the growth of tumor cells and may kill them by blocking some of the enzymes needed for cell growth. Durvalumab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Adding AZD6738 to durvalumab may increase time without cancer in patients with non-small cell lung cancer, following treatment with chemotherapy and surgery.
Recruiting
2 awards
Phase 3
10 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Crossroads Cancer Center?
Crossroads Cancer Center is a medical facility located in Effingham, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Breast cancer and other specialties. Crossroads Cancer Center is involved with conducting 357 clinical trials across 447 conditions. There are 3 research doctors associated with this hospital, such as Bryan A. Faller, James L. Wade, and Harold Yoon, MD.
Where is Crossroads Cancer Center located?
Crossroads Cancer Center is located at 905 Medical Park Drive, Effingham, IL 62401, approximately 0.93 miles from downtown Effingham.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Crossroads Cancer Center, please refer to their official website for direct contact information. For additional support, Cancer Care Specialists of Illinois can be contacted at the following clinic numbers: Decatur Clinic - 217-876-6600, Effingham Clinic - 217-342-2066, Centralia Clinic - 618-436-5410, and O’Fallon Clinic - 618-416-7970.
What insurance does Crossroads Cancer Center accept?
The Crossroads Cancer Center accepts a wide range of insurance plans, including but not limited to Aetna Choice POS, Anthem PPO, BCBS Blue Card PPO, Cigna HMO, and United Healthcare AARP Secure Horizons HMO. They do not accept Medicare or Medicaid, with exceptions for specific plans such as United Healthcare AARP Secure Horizons HMO and Aetna Medicare Advantage PPO. For insurance plans not listed, contacting your insurance provider or the hospital directly is recommended to inquire about coverage.
What awards or recognition has Crossroads Cancer Center received?
Crossroads Cancer Center, affiliated with Cancer Care Specialists of Illinois, is renowned for its contributions to cancer research and care. It engages in research studies and clinical trials in partnership with prestigious organizations such as the National Cancer Institute and the American Society of Clinical Oncology. These efforts have garnered the center numerous accolades, solidifying its status as a top-tier cancer care provider.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.